XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses        
Research and development $ 20,276 $ 10,106 $ 33,807 $ 17,516
General and administrative 4,457 4,396 8,890 7,855
Total operating expenses 24,733 14,502 42,697 25,371
Loss from operations (24,733) (14,502) (42,697) (25,371)
Other income, net 1,224 869 2,633 1,443
Change in fair value of warrant liabilities 12,293 (31,274) 22,353 (44,610)
Net loss (11,216) (44,907) (17,711) (68,538)
Other comprehensive loss:        
Unrealized loss on available-for-sale securities, net (30)   (74)  
Comprehensive loss $ (11,246) $ (44,907) $ (17,785) $ (68,538)
Basic earnings per share of common stock $ (0.13) $ (0.92) $ (0.21) $ (1.61)
Diluted earnings per share of common stock $ (0.13) $ (0.92) $ (0.21) $ (1.61)
Weighted-average common shares outstanding, basic 77,156,068 42,278,411 77,141,196 36,133,906
Weighted-average common shares outstanding, diluted 77,156,068 42,278,411 77,141,196 36,133,906
Series X and Series X1 Non-voting Convertible Preferred Stock [Member]        
Other comprehensive loss:        
Basic earnings per share $ (7.46) $ (51.29) $ (11.78) $ (89.60)
Diluted earnings per share $ (7.46) $ (51.29) $ (11.78) $ (89.60)
Weighted-average shares outstanding, basic 114,508 114,508 114,508 114,508
Weighted-average shares outstanding, diluted 114,508 114,508 114,508 114,508